Collaborative efforts to develop adverse outcome pathways: Oxidative DNA damage leading to chromosomal aberrations and mutations
E. Cho
(1, 2)
,
A. Allemang
(3)
,
Marc Audebert
(4)
,
V. Chauhan
(1)
,
S. Dertinger
(5)
,
G. Hendriks
,
M. Luijten
(6)
,
F. Marchetti
(1, 2)
,
L. Peel
(7)
,
S. Pfuhler
(3)
,
D. J. Roberts
(8)
,
K. Trenz
(9)
,
C. L. Yauk
(1, 2)
1
Health Canada
2 Carleton University
3 Procter and Gamble
4 ToxAlim-MeX - Métabolisme et Xénobiotiques
5 Litron Laboratories
6 RIVM - National Institute for Public Health and the Environment [Bilthoven]
7 Health and Environmental Sciences Institute
8 Charles River
9 Boehringer Ingelheim International GmbH
2 Carleton University
3 Procter and Gamble
4 ToxAlim-MeX - Métabolisme et Xénobiotiques
5 Litron Laboratories
6 RIVM - National Institute for Public Health and the Environment [Bilthoven]
7 Health and Environmental Sciences Institute
8 Charles River
9 Boehringer Ingelheim International GmbH
Marc Audebert
- Fonction : Auteur
- PersonId : 746476
- IdHAL : marc-audebert
- ORCID : 0000-0001-7898-6912
- IdRef : 073330434
G. Hendriks
- Fonction : Auteur